167 related articles for article (PubMed ID: 3900237)
1. Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy.
Young DB; Harnisch JP; Knight J; Buchanan TM
J Infect Dis; 1985 Nov; 152(5):1078-81. PubMed ID: 3900237
[No Abstract] [Full Text] [Related]
2. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
4. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy.
Melsom R; Naafs B; Harboe M; Closs O
Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205
[No Abstract] [Full Text] [Related]
5. Use of a polysulfone membrane support for immunochemical analysis of a glycolipid from Mycobacterium leprae.
Young DB; Fohn MJ; Buchanan TM
J Immunol Methods; 1985 May; 79(2):205-11. PubMed ID: 3889165
[TBL] [Abstract][Full Text] [Related]
6. Specific antigen and antibody to Mycobacterium leprae in the cryoprecipitate of a patient with Lucio phenomenon.
Drosos AA; Brennan PJ; Elisaf MS; Stefanou SG; Papadimitriou CS; Moutsopoulos HM
Rheumatol Int; 1986; 6(2):93-4. PubMed ID: 2429360
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to phenolic glycolipid-1 of Mycobacterium leprae in urine of leprosy patients.
Patil SA; Katoch K; Singh KP; Ramu G; Sengupta U
J Infect Dis; 1990 Jul; 162(1):281-2. PubMed ID: 2192009
[No Abstract] [Full Text] [Related]
8. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy.
Chanteau S; Cartel JL; Celerier P; Plichart R; Desforges S; Roux J
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):735-43. PubMed ID: 2681456
[TBL] [Abstract][Full Text] [Related]
9. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
Brett SJ; Draper P; Payne SN; Rees RJ
Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
[TBL] [Abstract][Full Text] [Related]
10. Isolation of the Mycobacterium leprae-specific glycolipid antigen, phenolic glycolipid-I, from formalin-fixed human lepromatous liver.
Izumi S; Sugiyama K; Fujiwara T; Hunter SW; Brennan PJ
J Clin Microbiol; 1985 Oct; 22(4):680-2. PubMed ID: 3908478
[TBL] [Abstract][Full Text] [Related]
11. Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.
Drowart A; Chanteau S; Huygen K; De Cock M; Cartel JL; De Bruyn J; Launois P; Yernault JC; Van Vooren JP
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):29-34. PubMed ID: 8326178
[TBL] [Abstract][Full Text] [Related]
12. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
13. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
[TBL] [Abstract][Full Text] [Related]
14. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
15. Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy.
Yoder L; Naafs B; Harboe M; Bjune G
Lepr Rev; 1979 Jun; 50(2):113-21. PubMed ID: 396427
[No Abstract] [Full Text] [Related]
16. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
[TBL] [Abstract][Full Text] [Related]
17. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.
Cho SN; Yanagihara DL; Hunter SW; Gelber RH; Brennan PJ
Infect Immun; 1983 Sep; 41(3):1077-83. PubMed ID: 6193065
[TBL] [Abstract][Full Text] [Related]
18. An enzyme immunoassay titrating IgM antibody against phenolic glycolipid for diagnosis of lepromatous leprosy.
Ralhan R; Band AH; Roy A; Hajini GH; Sharma AK; Talwar GP
Indian J Med Res; 1985 Aug; 82():110-5. PubMed ID: 3902635
[No Abstract] [Full Text] [Related]
19. PLG I antigen and antibody detection in the control of leprosy in French Polynesia.
Chanteau S; Cartel JL; Plichart R; Roux J; Bach MA
Acta Leprol; 1989; 7 Suppl 1():128-9. PubMed ID: 2503968
[No Abstract] [Full Text] [Related]
20. Methods for the detection of a specific Mycobacterium leprae antigen in the urine of leprosy patients.
Kaldany RR; Maasho K; Ohman R; Reitz-Vick D; Britton S; Lefford MJ
Scand J Immunol; 1987 Jan; 25(1):37-43. PubMed ID: 3544198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
